BioCentury

8:00 AM GMT, Feb 19, 2007
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Strategy

Outsourcing from Japan

While a growing number of companies in the West are moving at least some of their R&D activities to Asia, Atlas Venture and a group of Japanese investors are thinking in the reverse direction. Shogoo Pharmaceuticals K.K., which recently raised 1.6 billion ($13.6 million) in a series A round, will be based in Japan but do its R&D in Europe. The idea behind the Japanese home base is to take advantage of a perceived demand

Read the full 756 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.